The CADEUS study: methods and logistics

This publication has 24 references indexed in Scilit:

• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
  BMJ, 2005
• The withdrawal of rofecoxib
  Pharmacoepidemiology and Drug Safety, 2005
• Prescription du célécoxib (Célébrex®) lors de sa commercialisation : une étude conduite à partir de la base de données du régime général de l’assurance maladie de la région Aquitaine
  Therapies, 2005
• Lessons from the withdrawal of rofecoxib: France has policy for overall assessment of public health impact of new drugs
  BMJ, 2004
• Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors
  American Heart Journal, 2004
• COX‐2‐selective inhibitors and the risk of upper gastrointestinal bleeding in high‐risk patients with previous gastrointestinal diseases: a population‐based case–control study
  Alimentary Pharmacology & Therapeutics, 2004
• Differences between clinical trials and postmarketing use
  British Journal of Clinical Pharmacology, 2003
• Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
  JAMA, 2000
• Prescriber profile and postmarketing surveillance
  The Lancet, 1993
• Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.
  BMJ, 1991